Clinical Trial Update: The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and immunogenicity of a recombinant hepatitis B vaccine in healthy neonates; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Recombinant hepatitis B vaccine (hepatitis B vaccine, recombinant)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Virus Disease, DNA Virus Infections | Phase 3 | Status: COMPLETED